ÂÜÀòÂÒÂ×

David Simpson has a diverse work experience in the healthcare industry. David currently holds the position of Chief of Strategy and Partnerships at Southern Cross Healthcare, where they play a key role in shaping the organization's strategic direction. Prior to this, they were a Strategic Adviser to the CEO at the same company. In addition, they serve as a Non Executive Director at various healthcare organizations, including TBI Health Group New Zealand, Raise (formerly EAPworks), Auckland Radiation Oncology, Intra - Image Guided Healthcare, and Capital Endoscopy Partnership. David also has experience as an Industry Mentor at MedTech Actuator. Furthermore, they have been a part of the Advisory Board for Health and Business Schools (Health Innovation) at Bond University. Previously, they were the Head of Strategy and Innovation at Ramsay Health Care and the Head of the NZ Practice at Accenture Health ANZ, where they led the company's health practice and supported healthcare strategy and innovation. Overall, David Simpson's work experience demonstrates their expertise in healthcare strategy, innovation, and leadership.

David Simpson's education history is as follows:

David attended Auckland University of Technology from 1996 to 1999, where they pursued a degree in Physiotherapy.

In 2002, they enrolled at The University of Auckland, completing their degree in Business in 2003. During their time at the university, they received the Dean's Senior Prize for Academic Excellence.

David participated in the EY Executive Programme at the University of Virginia Darden School of Business in 2012.

David furthered their education by completing a Corporate Strategy program at the Melbourne Business School in 2014.

In 2016, David attended Harvard University and undertook a program on Negotiation and Leadership.

In 2017, they completed the Advanced Management Programme (AMP) at The Wharton School.

Most recently, David attended the Institute of Directors in New Zealand, where they pursued the Company Directors Course. It is important to note that the end year for this program is not specified but is expected to be in the year 2022.